Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
FIASP, FIASP FLEXTOUCH, FIASP PENFILL (Novo Nordisk Pharmaceuticals Pty Ltd)
Product name
FIASP, FIASP FLEXTOUCH, FIASP PENFILL
Date registered
Evaluation commenced
Decision date
Approval time
190 working days (255)
Active ingredients
insulin aspart (rys)
Registration type
EOI
Indication
FIASP, FIASP FLEXTOUCH, FIASP PENFILL (solution for injection) is now also indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.